Led by new CEO Dr. Yvonne Greenstreet, Alnylam Pharmaceuticals has a stated ambition to transition the RNA interference therapeutics trailblazer to a top 5 biotech – measured by market capitalization – within the next five years.

Hal Barron, who guided the reinvigoration of the pharmaceutical direction at GlaxoSmithKline, is departing the company as GSK undergoes a planned demerger later during 2022.

Leading market research patient recruitment firm Rare Patient Voice LLC announced another first-quarter 2022 round of promotions and changes to staff, following an initial round earlier in January.

Evoke announced three key leadership hires to the global health and wellness agency’s executive team.

imre named Anna Kotis as the new president of imre Health, as the digital powerhouse continues to elevate its life sciences offerings and catalyze year-over-year growth into more robust digital AOR engagements.

M Booth Health named Stacey Bernstein its new CEO on the heels of the global health communications consultancy’s strongest performing year marked by double-digit growth and multi-million dollar account wins. Bernstein replaces Tim Bird as he transitions into a consultative role.

IPG Health Network announced that Franklin Williams joined the AREA 23 executive leadership team as EVP, director of experience design, reporting to chief creative officer Tim Hawkey.

Omnicom Health Group (OHG) announced the promotion of Gena M. Pemberton to Chief Diversity, Equity, and Inclusion Officer.

Ogilvy announced that Adam Hessel was appointed Chief Creative Officer of Ogilvy Health. In this role, Hessel is overseeing all creative output for Ogilvy Health in North America and serving on Ogilvy Health’s executive leadership team.

QBFox Healthcomm, a full-service healthcare agency nearing its fourth anniversary, entered 2022 with new growth, new talent, and a renewed story to tell.